Schizophrenia Research
Volume 104, Issue 1 , Pages 307-308, September 2008

Erratum to “Metabolic syndrome in first episode schizophrenia — A randomized double-blind controlled, short-term prospective study” [Schizophrenia Research 101 (2008) 266­272]

  • Sahoo Saddichha

      Affiliations

    • National Tobacco Control Program, Swasthya Bhavan, Sector V, Kolkata, India
    • Corresponding Author InformationCorresponding author. Cell.: +91 9836530262.
  • ,
  • Narayana Manjunatha

      Affiliations

    • Central Institute of Psychiatry, Ranchi, India
  • ,
  • Shahul Ameen

      Affiliations

    • St. John's Hospital, Kattappana, Idukki, Kerala, India
  • ,
  • Sayeed Akhtar

      Affiliations

    • Central Institute of Psychiatry, Ranchi, India

published online 01 July 2008.

Article Outline

 

The author regrets that in the above published article, incorrect information appeared in Table 2b. The correct table is printed on the following page. The author apologises for any inconvenience caused.

Table 2b. Comparison of fasting blood sugar (FBS), systolic (SBP) and diastolic blood pressure (DBP) from baseline to endpoint between various groups
FBS (mg%)FBS (mg%)SBP (mm Hg)SBP (mm Hg)DBP (mm Hg)DBP (mm Hg)
(Baseline)(Baseline)(Endpoint)(Endpoint)(Endpoint)(Endpoint)
AlMFAlMFAlMFAlMFAlMFAlMF
Control group (n(all)=51;80.880.381.580.780.381.6117.0118.0115.6117.0118.0115.777.778.676.277.678.776.3
m=30; f=21)(6.3)(6.7)(5.7)(6.4)(6.8)(5.7)(5.9)(6.1)(5.4)(5.8)(6.2)(5.4)(5.5)(5.0)(5.9)(5.5)(5.0)(6.0)
Treatment group-olanzapine81.779.783.988.489.487.2116.6118.1115.0125.2127.9122.576.878.874.781.483.978.8
(n(all)=35; m=18; f=17)(10.7)(11.7)(9.6)(18.0)(22.2)(12.8)(11.2)(8.8)(13.3)(8.7)(6.3)(10.2)(7.6)(6.7)(8.0)(8.4)(6.0)(9.9)
Treatment group-risperidone83.983.184.888.290.385.7118.9121.2116.2123.0126.1119.576.178.673.079.781.178.1
(n(all)=33; m=18; f=15)(11.8)(12.4)(11.6)(11.3)(12.1)(10.2)(11.6)(10.1)(13.2)(9.2)(5.0)(11.6)(9.4)(6.4)(11.6)(7.6)(5.8)9.3)
Treatment group-haloperidol81.280.382.088.088.287.8118.4117.9118.9119.0118.6119.577.177.576.679.279.279.2
(n(all)=31; m=16; f=15)(9.5)(9.0)(10.3)(15.4)(16.8)(14.4)(7.4)(6.2)(8.6)(4.5)(4.5)(4.6)(4.6)(4.4)(4.9)(4.9)(4.1)(5.7)
F value(df=3) 3.8 a3.3 b1.3(df=3) 11.6 c30.9 c2.8 d(df=3) 4.3 e16.8 c1.5

Al=All subjects; M=Male subjects; F=female subjects.

aSignificant at p=0.011.

bSignificant at p=0.023.

cSignificant at p b 0.001.

dSignificant at p=0.044.

eSignificant at p=0.006.

PII: S0920-9964(08)00273-9

doi:10.1016/j.schres.2008.05.023

Refers to article:

  • Metabolic syndrome in first episode schizophrenia — A randomized double-blind controlled, short-term prospective study , 13 February 2008

    Sahoo Saddichha, Narayana Manjunatha, Shahul Ameen, Sayeed Akhtar
    Schizophrenia Research April 2008 (Vol. 101, Issue 1, Pages 266-272)

Schizophrenia Research
Volume 104, Issue 1 , Pages 307-308, September 2008